What peridevice leaks after LAAO mean for patient health
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
The study’s authors explored data from more than 50,000 LAAO patients. All data came from the LAAO Registry, a collaboration between the American College of Cardiology (ACC), U.S. Food and Drug Administration (FDA), Society for Coronary Angiography and Interventions (SCAI), CMS and Boston Scientific. All procedures were performed from January 2016 to December 2019 using Boston Scientific’s Watchman 2.5 device. While 58.4% of patients were male, 93.1% were white.
Overall, 73.4% of patients had no residual leaks after the procedure. Small leaks (>5 mm) were seen in 25.8% of patients, and large leaks were seen in just 0.7% of patients.
The study’s primary endpoint — a composite of stroke, transient ischemic attack or systemic embolization — was seen in 3.49% of patients with small leaks, 3.13% of patients with large leaks and 2.98% of patients with no leaks. Major adverse events and major bleeding events were also more common among patients with small leaks than patients with no leaks or patients with large leaks.
The mortality rate, however, was higher among patients with large leaks (7.96%) than patients with no leaks (5.97%) or small leaks (6.41%).
“Our findings have important implications for procedural techniques and post-procedural management,” wrote lead author Mohamad Alkhouli, MD, an interventional cardiologist at Mayo Clinic in Rochester, Minnesota, and colleagues. “To mitigate the risk of future ischemic events, efforts should be made to achieve complete seal of the left atrial appendage when possible. This requires a comprehensive approach that includes adequate pre-procedural imaging and good understanding of the LAA anatomy, the pros and cons of the occluder device, and the mechanism of peridevice leak. Fortunately, second-generation devices are now available and have been associated with a lower incidence of both small and large leaks compared with first-generation devices.”
The authors also highlighted the need for additional research on the treatment of small residual leaks after LAAO and how the risk of such leaks can be minimized going forward.
Related Left Atrial Appendage Occlusion Content:
Older LAAO patients, especially women, face a higher risk of complications
Same-day discharge after LAAO associated with strong outcomes, significant cost savings
New LAA occluder technology and the debate on echo vs. CT image guidance
VIDEO: Advances in left atrial appendage occlusion technology — Interview with Devi Nair, MD
Amulet vs. Watchman: LAA occluder devices compared in new head-to-head trial
Abbott’s LAA closure solution for AFib patients gains FDA approval
Key interventional cardiology takeaways from ACC.22
LAAO outcomes significantly worse among women
Confirmed: Watchman FLX LAAC device safe for nonvalvular AFib patients
Cardiologist makes history, completes LAAO with new 3D ICE catheter
Reference: